The thiazolidinedione, troglitazone. does not initiate ventricular cardiomyocyte hypertrophy in vitro but may sensitise cardiomyocytes to the hypertrophic effects of serum growth factors

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)
Original languageEnglish
Pages (from-to)237-244
Number of pages8
JournalEuropean Journal of Pharmacology
Volume390
Publication statusPublished - 01 Oct 2000

Cite this